| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/26/2006 | EP1648914A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 04/26/2006 | EP1648913A2 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 04/26/2006 | EP1648521A1 Compositions and methods for treating cardiac dysfunction |
| 04/26/2006 | EP1648520A1 Compounds and methods for downregulating the effects of tgf-beta |
| 04/26/2006 | EP1648519A2 Lipid encapsulated interfering rna |
| 04/26/2006 | EP1648503A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 04/26/2006 | EP1648481A1 Viral vectors |
| 04/26/2006 | EP1648477A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/26/2006 | EP1648233A2 Mutants of vaccinia virus as oncolytic agents |
| 04/26/2006 | EP1499731A4 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1218514B1 Designing immunogens |
| 04/26/2006 | EP1053313B1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences |
| 04/26/2006 | EP1032697B1 High efficiency retroviral vectors that contain none of viral coding sequences |
| 04/26/2006 | EP1002108B1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 04/26/2006 | EP0966536B1 Factor x analogues with a modified protease cleavage site |
| 04/26/2006 | EP0811057B1 Viral preparations, vectors, immunogens, and vaccines |
| 04/26/2006 | CN1763199A Thioredoxin gene of Schistosoma japonicum (Chinese Mainland Strain) and its cloning expression method and application |
| 04/26/2006 | CN1763195A Human Nanog gene and its encoded protein and application |
| 04/26/2006 | CN1763192A Prawn white spot syndrome virus apoptosis suppressor and preparation and application thereof |
| 04/26/2006 | CN1763089A C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 04/26/2006 | CN1762498A Use of new castle disease virus infected genome |
| 04/26/2006 | CN1762497A Method for improving study and memory capability |
| 04/26/2006 | CN1762496A Genetic drug for targeted treatment of liver cancer and its preparation process |
| 04/26/2006 | CN1762492A CD40 binding molecules and CTL peptides uses in pharmic composition for treating tumors |
| 04/26/2006 | CN1253551C Genetically modified tumor-targeted bacteria with reduced virulence |
| 04/26/2006 | CN1253470C Treatment of inflammatory disease |
| 04/26/2006 | CN1253469C Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof |
| 04/26/2006 | CN1253220C Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 04/26/2006 | CN1253208C Use of antibodies against CD2O for treatment of graft versus host disease |
| 04/25/2006 | USRE39078 Recombinant adenoviruses for gene therapy in cancers |
| 04/25/2006 | US7034142 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 04/25/2006 | US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 04/25/2006 | US7034132 Nucleic acid sequences that encode G- coupled protein-receptor related polypeptides; diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving these human nucleic acids and proteins |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034115 Transposase and method of gene modification |
| 04/25/2006 | US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7034010 Gene delivery vectors, such as, for example, recombinant FIV vectors, and methods of using such vectors are provided for use in treating or preventing retinal diseases of the eye and diseases of the brain associated with lysosomal storage |
| 04/25/2006 | US7034008 Unitary catheter drug delivery device for delivering polynucleotide to cardiac tissue of the patient, capable of modulating an electrical property of the heart, and designed to suppress K channels; electrode to detect position of the device within the patient |
| 04/25/2006 | US7033995 Production of radial glial cells |
| 04/25/2006 | US7033834 Comprise the gene of interest; and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; use in gene therapy |
| 04/25/2006 | US7033831 Pluripotent pancreatic tissue for generating differentiated islets of langerhans; drug screening; regeneration medicine; antidiabetic agents |
| 04/25/2006 | US7033830 Antisense modulation of MyD88 expression |
| 04/25/2006 | US7033826 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033791 Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same |
| 04/25/2006 | US7033782 Compositions and methods for non-targeted activation of endogenous genes |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033755 Diagnostics and therapeutics for glaucoma |
| 04/25/2006 | US7033750 Recombinant P53 adenovirus methods and compositions |
| 04/25/2006 | US7033585 Immunologically privileged cells and uses thereof |
| 04/25/2006 | CA2236912C Vectors and methods for gene transfer to cells |
| 04/20/2006 | WO2006042254A2 Adjuvant for dna vaccines |
| 04/20/2006 | WO2006042237A2 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | WO2006042143A2 Glycine riboswitches, methods for their use, and compositions for use with glycine riboswitches |
| 04/20/2006 | WO2006041617A1 Biodegradable cationic polymers |
| 04/20/2006 | WO2006041205A1 Angiogenesis promoter |
| 04/20/2006 | WO2006041192A1 Medicinal compositions containing apoptosis inducer |
| 04/20/2006 | WO2006041157A1 Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody |
| 04/20/2006 | WO2006040357A2 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| 04/20/2006 | WO2006040330A2 Improved adenoviral vectors and uses thereof |
| 04/20/2006 | WO2006039806A1 Depression of herg k+ channel function in mammalian cells and applications to the control of cancer cells division |
| 04/20/2006 | WO2006039792A1 Method of treating autoimmune diseases |
| 04/20/2006 | WO2006002627A3 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 04/20/2006 | WO2005118802A3 Targeting pseudotyped retroviral vectors |
| 04/20/2006 | WO2005091716A3 Annexin ii and uses thereof |
| 04/20/2006 | WO2005066371A3 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 04/20/2006 | WO2005049832A3 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE |
| 04/20/2006 | WO2004108088A3 Methods and compositions for interferon therapy |
| 04/20/2006 | WO2004044164A3 Method for identifying risk of melanoma and treatments thereof |
| 04/20/2006 | US20060084623 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus |
| 04/20/2006 | US20060084622 Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/20/2006 | US20060084621 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 04/20/2006 | US20060084620 RNA interference in respiratory epitheial cells |
| 04/20/2006 | US20060084619 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture |
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084617 Methods for delivery of nucleic acids |
| 04/20/2006 | US20060084602 Platelet-derived growth factor compositions and methods of use thereof |
| 04/20/2006 | US20060084595 Complex comprising OCIF and polysaccharide |
| 04/20/2006 | US20060084172 Method for producing stem cells with increased developmental potential |
| 04/20/2006 | US20060084149 Forming complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060084109 Regulated aptamer therapeutics |
| 04/20/2006 | US20060084091 Methods and compositions for polypeptide engineering |
| 04/20/2006 | US20060084086 Proteins, polynucleotides encoding them and methods of using the same |
| 04/20/2006 | US20060084053 Nucleotide sequence coding methyltransferase for use as tool in diagosing tumor disorders |
| 04/20/2006 | US20060083780 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity |
| 04/20/2006 | US20060083768 Method of thickening a coating using a drug |
| 04/20/2006 | US20060083756 Immunogens; replication-defective; antibodies; host cells; kits |
| 04/20/2006 | US20060083755 Vaccine for feline infectious peritonitis |
| 04/20/2006 | US20060083752 Novel compounds |
| 04/20/2006 | US20060083749 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/20/2006 | US20060083744 B7-H1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |